NHS England - Market Engagement - Pre Exposure Prophylaxis (PrEP) for prevention of HIV - The PrEP Impact Clinical Trial

Arden & GEM CSU on behalf of the NHS England - Specialised Commissioning would like to notify all potential bidders about a 'Market Engagement Event' which has been planned to take place on Monday 24th April 2017. This event has been arranged to provide information and seek feedback about the upcoming procurement of licensed tenofovir disoproxil/emtricitabine combined tablet formulations to meet the aims and objectives of the PrEP Impact Clinical trial. To attend this event please email your organisation's and attendees' details to mark.perkins@nhs.net Once you have confirmed your intention to attend, a briefing document will be provided including further details of the event, together with a short questionnaire to be completed and returned on or before the 19th April 2017. The event will include a briefing for all potential suppliers as well as the opportunity for suppliers to meet individually with members of the NHS England and PHE PrEP Impact Trial team. The event will be held in central London on Monday 24th April 2017.